$38.02
Value $1.5B
AMN Healthcare ServicesvsGE Vernova
AMN and GEV stock compared: price, dividend, valuation and results, from SEC filings.
+1.60%
$803.13
Value $216B
AMN Healthcare Services (AMN) has a market value of $1.5B and GE Vernova (GEV) $216B. Over the last year, with dividends, AMN moved +129.2% and GEV +39.9%. The P/E is 13.5 for AMN and 20.9 for GEV. Dividend yield: AMN none, GEV 0.25%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
AMN$1.5B
GEV$216B
GEV is 147 times AMN
Revenue, 12 months
AMN$3.5B
GEV$44.0B
GEV is 13 times AMN
Net income, 12 months
AMN$109M
GEV$10.4B
GEV is 95 times AMN
Operating margin
AMN5.8%
GEV6.4%
0.6 points apart
ROIC
AMN8.9%
GEV19.5%
10.6 points apart
P/E
AMN13.5
GEV20.9
GEV is 1.5 times AMN
Dividend yield
AMN0.0%
GEV0.3%
0.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
AMN+129.2%
GEV+39.9%
| Period | AMNWith dividends | GEVWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +129.2%Price +129.2% | +39.9%Price +39.6% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
AMNAMN Healthcare ServicesGEVGE Vernova
Valuation
AMNGEV| Price | $38.02 | $803.13 |
|---|---|---|
| Market value | $1.5B | $216B |
| Enterprise value (EV) | $2.0B | $203B |
| P/E | 13.5 | 20.9 |
| P/E, 5-year median | 14.0 | – |
| P/B | 1.9 | 19.0 |
| EV/EBIT | 9.7 | 71.6 |
| Free cash flow yield | 22.3% | 7.9% |
Results and growth
AMNGEV| Revenue, 12 months | $3.5B | $44.0B |
|---|---|---|
| Net income, 12 months | $109M | $10.4B |
| Free cash flow, 12 months | $327M | $17.1B |
| Earnings per share, 12 months | $2.76 | $38.00 |
| Revenue growth, year on year | -8.5% | 9.0% |
| Revenue growth a year, past | +2.7%over 5 years | +8.7%over 3 years |
| EPS growth a year, past | – | – |
Margins and returns on capital
AMNGEV| Gross margin | 28.4% | 21.7% |
|---|---|---|
| Operating margin | 5.8% | 6.4% |
| Net margin | 3.1% | 23.5% |
| ROIC | 8.9% | 19.5% |
| ROE | 15.5% | 90.8% |
Balance sheet
AMNGEV| Cash | $256M | $16.8B |
|---|---|---|
| Total debt | $775M | $3.7B |
| Net debt / EBITDA | 1.4 | -4.1 |
| Interest cover | 6.1× | – |
Dividends and buybacks
AMNGEV| Dividend yield | – | 0.3% |
|---|---|---|
| Dividend per share, 12 months | – | $2.00 |
| Dividend growth a year, past | – | – |
| Buyback yield | – | 1.5% |
| Shareholder yield | – | 1.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, AMN Healthcare Services or GE Vernova?
By market value, GE Vernova ($216B) is about 147.3 times AMN Healthcare Services ($1.5B), at today's prices.
How did AMN and GEV stock do over the last 1 years?
Since November 12, 2025, AMN's price moved +129.2% and GEV's +39.6%. With dividends: AMN +129.2% (+129.2% a year), GEV +39.9% (+39.9% a year). Past returns do not predict future ones.
Which pays the higher dividend, AMN or GEV?
The dividend yield at today's price is none for AMN Healthcare Services and 0.25% for GE Vernova. Over the last twelve months they paid – and $2.00 per share.
What is the P/E of AMN and GEV?
At today's price, the P/E is 13.5 for AMN and 20.9 for GEV. It is the share price over the last twelve months' earnings per share.
Which has the higher profit margins, AMN Healthcare Services or GE Vernova?
Over the last twelve months, the net margin was 3.1% for AMN Healthcare Services and 23.5% for GE Vernova, and the operating margin 5.8% and 6.4%. Revenue was $3.5B and $44.0B.
Which is the better investment, AMN Healthcare Services or GE Vernova?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.